Biotest AG
OTC: BTTAY0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Jorg Schuttrumpf
- Employees
- 2,495
- Headquarters
- Dreieich, Germany
- IPO year
- 2022
- Market cap
- $1.9B
- Website
- https://www.biotest.com
Loading BTTAY…
Loading profile data…Frequently asked questions about BTTAY
What does Biotest AG (BTTAY) do?
Operating globally from its headquarters in Dreieich, Germany, Biotest AG is a pharmaceutical company established in 1946. It specializes in the research, development, manufacturing, and commercialization of biological medicines. The company's operations are structured across its Therapy, Plasma & Services, and Other divisions. Biotest's product...
Where does BTTAY trade?
Biotest AG (BTTAY) trades on the Other OTC.
What sector is BTTAY in?
Biotest AG (BTTAY) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Biotest AG?
Jorg Schuttrumpf is the chief executive officer of Biotest AG (BTTAY).
Where is Biotest AG headquartered?
Biotest AG is headquartered in Germany.
Does BTTAY pay a dividend?
Yes — Biotest AG (BTTAY) paid a trailing twelve-month dividend of USD 24.92 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did BTTAY go public?
Biotest AG (BTTAY) completed its initial public offering in 2022.
Is BTTAY an ADR?
Yes — BTTAY is an American Depositary Receipt; its underlying shares trade on a non-US exchange. Biotest AG reporting and dividends follow the underlying issuer.